Non-severe allergic transfusion reaction: A hidden cause of wastage of blood product and laboratory resources.
allergic
audit
blood wastage
transfusion reaction
Journal
Vox sanguinis
ISSN: 1423-0410
Titre abrégé: Vox Sang
Pays: England
ID NLM: 0413606
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
revised:
07
12
2022
received:
05
10
2022
accepted:
16
12
2022
pubmed:
7
1
2023
medline:
17
3
2023
entrez:
6
1
2023
Statut:
ppublish
Résumé
Blood transfusions are often needlessly aborted following a non-severe allergic reaction despite responding well to medication resulting into partial transfusion of the implicated blood product. This results in the wastage of untransfused blood component and resources spent on unnecessary laboratory work-up of these reactions. We aimed to review the amount of blood product and laboratory resource wastage associated with non-severe allergic transfusion reaction (ATR) in a tertiary care hospital. A total of 174,632 blood products were released and transfused during the study period (2019-2021). There were 336 adverse transfusion reactions with an estimated rate of 1.9 per 1000 blood products administered. Of 336, 145 (43%) were ATR, of which 141 (97%) were non-severe and 4 (3%) were severe. The most commonly associated symptom was found to be urticaria in 31 (22%). All non-severe ATR completely resolved with medication. Seventy-nine percent of the transfusions associated with non-severe ATRs were aborted, of which 37% were followed by additional transfusions. The estimated loss of blood product volume and the cost of non-severe ATR (including transfusion reaction work-up, discarded blood product and additional transfusion) was 11,185 ml (11 L) and Pakistani rupees 1,831,546 ($11,592.06 or €8598.78), respectively. Non-severe ATR was found to be associated with a significant proportion of laboratory resource wastage and that of blood product in our institution. Revision of institutional guidelines for management and lab work-up of transfusion reactions would be helpful in alleviating this unnecessary loss in a resource-constraint transfusion-setting.
Sections du résumé
BACKGROUND AND OBJECTIVES
OBJECTIVE
Blood transfusions are often needlessly aborted following a non-severe allergic reaction despite responding well to medication resulting into partial transfusion of the implicated blood product. This results in the wastage of untransfused blood component and resources spent on unnecessary laboratory work-up of these reactions.
MATERIALS AND METHODS
METHODS
We aimed to review the amount of blood product and laboratory resource wastage associated with non-severe allergic transfusion reaction (ATR) in a tertiary care hospital.
RESULTS
RESULTS
A total of 174,632 blood products were released and transfused during the study period (2019-2021). There were 336 adverse transfusion reactions with an estimated rate of 1.9 per 1000 blood products administered. Of 336, 145 (43%) were ATR, of which 141 (97%) were non-severe and 4 (3%) were severe. The most commonly associated symptom was found to be urticaria in 31 (22%). All non-severe ATR completely resolved with medication. Seventy-nine percent of the transfusions associated with non-severe ATRs were aborted, of which 37% were followed by additional transfusions. The estimated loss of blood product volume and the cost of non-severe ATR (including transfusion reaction work-up, discarded blood product and additional transfusion) was 11,185 ml (11 L) and Pakistani rupees 1,831,546 ($11,592.06 or €8598.78), respectively.
CONCLUSION
CONCLUSIONS
Non-severe ATR was found to be associated with a significant proportion of laboratory resource wastage and that of blood product in our institution. Revision of institutional guidelines for management and lab work-up of transfusion reactions would be helpful in alleviating this unnecessary loss in a resource-constraint transfusion-setting.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
193-198Informations de copyright
© 2023 International Society of Blood Transfusion.
Références
Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion. 2010;50:753-65.
Zoric L, Daurat G, Demattei C, Macheboeuf M, Boisson C, Bouix O, et al. Blood wastage reduction: a 10-year observational evaluation in a large teaching institution in France. Eur J Anaesthesiol. 2013;30:250-5.
Heitmiller ES, Hill RB, Marshall CE, Parsons BJ, Berkow LC, Barrasso CA, et al. Blood wastage reduction using Lean Sigma methodology. Transfusion. 2010;50:1887-96.
Collins RA, Wisniewski MK, Waters JH, Triulzi DJ, Yazer MH. Effectiveness of multiple initiatives to reduce blood component wastage. Am J Clin Pathol. 2015;143:329-35.
Delaney M, Wendel S, Bercovitz RS, Cid J, Cohn C, Dunbar NM, et al. Transfusion reactions: prevention, diagnosis, and treatment. Lancet. 2016;388:2825-36.
Tinegate H, Birchall J, Gray A, Haggas R, Massey E, Norfolk D, et al. Guideline on the investigation and management of acute transfusion reactions. Prepared by the BCSH Blood Transfusion Task Force. Br J Haematol. 2012;159:143-53.
Savage WJ, Tobian AA, Savage JH, Wood RA, Schroeder JT, Ness PM. Scratching the surface of allergic transfusion reactions. Transfusion. 2013;53:1361-71.
Goel R, Tobian AAR, Shaz BH. Noninfectious transfusion-associated adverse events and their mitigation strategies. Blood. 2019;133:1831-9.
Kracalik I, Mowla S, Basavaraju SV, Sapiano MRP. Transfusion-related adverse reactions: Data from the National Healthcare Safety Network Hemovigilance Module - United States, 2013-2018. Transfusion. 2021;61:1424-34.
Adkins BD, Lawicki S, Johnson M, Eichbaum Q. Mild allergic transfusion reactions: impact of associated clinical symptoms? Am J Clin Pathol. 2019;151:344-8.
Kasim J, Aldarweesh F, Connor JP. Blood product and laboratory resource wastage in non-severe allergic transfusion reactions: an opportunity for improvement. Transfus Med. 2019;29:338-43.
Karim F, Moiz B, Shamsuddin N, Naz S, Khurshid M. Root cause analysis of non-infectious transfusion complications and the lessons learnt. Transfus Apher Sci. 2014;50:111-7.
Crowder LA, Steele WR, Stramer SL. Infectious disease screening. In: Cohn CS, Delaney M, Johnson ST, Katz LM, editors. Technical manual. 20th ed. Bethesda: AABB Press; 2020. p. 173.
Centers for Disease Control and Prevention. National Healthcare Safety Network Biovigilance Component Hemovigilance Module Surveillance Protocol v2.6. Available from: www.cdc.gov/nhsn/pdfs/biovigilance/bv-hv-protocol-current.pdf. Accessed on 12 Aug 2022.
Ngo A, Masel D, Cahill C, Blumberg N, Refaai MA. Blood banking and transfusion medicine challenges during the COVID-19 pandemic. Clin Lab Med. 2020;40:587-601.
Rafiee MH, Kafiabad SA, Maghsudlu M. Analysis of blood donors' characteristics and deferrals related to COVID-19 in Iran. Transfus Apher Sci. 2021;60:103049.
Elnasser Z, Obeidat H, Amarin Z, Alrabadi N, Jaradat A, Alomarat D, et al. Prevalence of COVID-19 among blood donors: the Jordan University of Science and Technology experience. Medicine (Baltimore). 2021;100:e27537.
Tobian AA, Savage WJ, Tisch DJ, Thoman S, King KE, Ness PM. Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction. Transfusion. 2011;51:1676-83.
Savage WJ, Hamilton RG, Tobian AA, Milne GL, Kaufman RM, Savage JH, et al. Defining risk factors and presentations of allergic reactions to platelet transfusion. J Allergy Clin Immunol. 2014;133:1772-5.
Savage WJ, Tobian AA, Fuller AK, Wood RA, King KE, Ness PM. Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes. Transfusion. 2011;51:1716-22.
Bolton-Maggs P, Mistry H, Glencross H, Rook R, UK Transfusion Laboratory Collaborative. Staffing in hospital transfusion laboratories: UKTLC surveys show cause for concern. Transfus Med. 2019;29:95-102.
Novis DA, Nelson S, Blond BJ, Guidi AJ, Talbert ML, Mix P, et al. Laboratory staff turnover: a College of American Pathologists Q-probes study of 23 clinical laboratories. Arch Pathol Lab Med. 2020;144:350-5.
Chaffe B, Glencross H, Jones J, Staves J, Capps-Jenner A, Mistry H, et al. UK Transfusion Laboratory Collaborative: minimum standards for staff qualifications, training, competency and the use of information technology in hospital transfusion laboratories 2014. Transfus Med. 2014;24:335-40.